BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.010
0.00%
(0.00) 1D
Nov 9, 4:12:05 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
27.63M
Avg. vol.
9.97M
Volume
2.69M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
27.63M
Avg. vol.
9.97M
Volume
2.69M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
Benzinga
·
37 minutes ago
History Suggests Last Week's Selloff Was a Buying Opportunity - State Street SPDR S&P 500 ETF Trust (ARCA
BigGo Finance
·
4 hours ago
Goldman Sachs Panic Index Breaches Extreme 9.5 Threshold; History Shows S&P 500 Averaged 4.6% Gain Over Following Three Months
JournalArta
·
2 hours ago
Tech Stocks Now Cheaper Than S&P 500 for First Time Since 2017
The Motley Fool
·
14 hours ago
No Matter What Happens to the S&P 500 in November, These 3 Dividend Stocks Belong in Your Portfolio
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com